- AdventHealth
It’s late in the evening for Dr. Nathalie McKenzie, gynecologic oncologist at the AdventHealth Cancer Institute, yet her day is not over. She grabs water, sits down in front of her computer and logs on to a Zoom call, but this is no typical meeting – this is one of her passions.
“Giving back by mentoring brings me joy knowing that I’m sharing knowledge to help save lives,” said McKenzie. “I didn’t have access to this type of mentorship when I went through my training, and I want to be able to open doors for these budding physicians who can make difference.”
Dr. McKenzie’s dedication extends far beyond the walls of AdventHealth. Collaborating with gynecologic oncologists at Harvard Massachusetts General Hospital and International Society of Gynecologic Cancer, she mentors physicians in developing countries to better care for women with gynecologic cancers. Despite the challenges, she ensures these mentoring sessions happen weekly, currently through multinational Zoom sessions. She also occasionally visits low-resource countries to offer her expertise. Her last in-person visit was to Haiti in 2020, leaving an indelible impact on local medical professionals.
During these sessions, McKenzie dives deep into discussing cases of the week, soliciting thoughts on procedures and surgeries, and offering invaluable advice on the proper next steps. Her commitment to mentorship extends beyond surgical skills, to recently, the research field. Her invitation to the American Association Cancer for Research in July 2023 marked a milestone in her mentoring journey, where she coached young, promising cancer researchers through their clinical trial proposals.
“Mentoring has many facets; it’s one thing to mentor, but it’s special when you can follow through and make a difference in a mentee’s trajectory,” Dr. McKenzie emphasizes. “When we mentor, we must also be prepared to make introductions, assist with networking, and teach these skills to identify opportunities for our mentees.”
"Dr. McKenzie's guidance has been pivotal in shaping my journey from fellowship to practice,” said Dr. Nnamdi Gwacham, who was one of Dr. McKenzie’s fellows and is now the assistant professor in surgery for gynecologic oncology at City of Hope in Phoenix, Arizona. “She not only recognized my potential but also nurtured it, pushing me to bloom in my career. Her unwavering support, constructive feedback, and opportunities for growth have been invaluable. I am grateful for her mentorship as it continues to guide me through uncharted territory, instilling confidence and refining my skills as a gynecologic oncologist in my new position.”
Within AdventHealth, Dr. McKenzie serves as the Gynecologic Fellowship Director, ensuring the next generation of specialists receives comprehensive training. In addition to that work, she has mentored hundreds of medical students, residents, fellows, and early-career physicians over the last two decades, shaping the landscape of health care both locally and globally.
Dr. McKenzie sees Women’s History Month as more than just a time to reflect. “Our country, and society, has made significant strides toward increasing access to career opportunities for women,” she says. “I’m grateful for those opportunities because it’s allowed me to pursue my passion, and I hope I can inspire other women to step into the light and lead in the medical field.”
Recent News
AdventHealth Cancer Institute Advances the Use of CAR T-Cell Therapy for Multiple Myeloma
CAR-T therapies have emerged as new treatment options for certain types of cancer through a one-time infusion that can lead to long-lasting remission.
AdventHealth Graduate Medical Education Program Celebrates 50 Years
Growing from a family practice residency to 24 accredited programs, AdventHealth’s Graduate Medical Education (GME) program celebrates 50 years.
New Clinical Trial Explores Digital Intervention for Apathy in Late-life Depression
Afflicting 30-50% of patients with late-life depression, apathy is a challenging psychiatric syndrome in older adulthood that can result in lack of motivation leading to poor self-care, physical...
AdventHealth Performs Central Florida’s First Liver Transplant for Unresectable Colorectal Liver Metastases
In June 2025, AdventHealth Abdominal Transplant Surgeon and Surgical Oncologist Ryan Day, MD, worked with a multidisciplinary team to perform Central Florida’s first liver transplant for unresectable...
AdventHealth Neuroscience Institute First in Florida to be Recognized as a GammaTile Center of Excellence
GammaTile is the first and only tile-based radiation therapy for the treatment of
operable brain tumors. The AdventHealth Neuroscience Institute began performing GammaTile procedures in 2021 and was...
An AdventHealth Collaboration Explores the Impact of Microgravity and Electrical Stimulation on Muscle Cell Health in Space
Using a muscle lab-on-chip model aboard the International Space Station (ISS), AdventHealth Translational Research Institute’s Dr. Paul Coen has been working with a multidisciplinary team from the...
AdventHealth Neuroscience Institute Among First in U.S. to Offer Phase IIa Clinical Trial of Troculeucel for Moderate Alzheimer’s Disease
While most clinical trials for Alzheimer’s disease have focused on patients with early or mild cognitive impairment, roughly 30% of those with Alzheimer’s have moderate stage disease for which there...
AdventHealth Translational Research Institute Selected as Clinical Site for National Study of Muscle, Mobility and Aging (SOMMA)
Under the leadership of Scientific Director and Principal Investigator Bret H. Goodpaster, PhD, the AdventHealth Translational Research Institute (TRI) is now enrolling men and women 70 years of age...
AdventHealth Neuroscience Institute Administers First Dose of Investigative NK Cell Therapy to Person with Alzheimer’s Disease
Under a single compassionate use Investigational New Drug (IND) authorization cleared by the U.S. Food and Drug Administration (FDA), the AdventHealth Neuroscience Institute worked with NKGen Biotech...
New Study Published in the New England Journal of Medicine Shows the Addition of Regional Nodal Irradiation Does Not Decrease Rate of Invasive Breast Cancer Recurrence in Patients with Negative Axillary Nodes Following Neoadjuvant Chemotherapy
Findings of the phase III, multicenter, randomized NSABP B-51-RTOG 1304 clinical trial were recently published in the New England Journal of Medicine with AdventHealth Cancer Institute’s Dr. Mamounas...
AdventHealth Study Exploring the Use of MR-Guided Focused Ultrasound (MRgFUS) to Disrupt the Blood-Brain Barrier for Treatment of Alzheimer’s Disease
Under the leadership of Dr. Valeria Baldivieso and Dr. Chandan Reddy, the AdventHealth Research Institute is the first and only site in Orlando offering the Exablate Blood-Brain Barrier (BBB)...
AdventHealth Research Institute Offers Phase II Clinical Trial of Etanercept for Treatment of Blast-Induced Tinnitus
Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt...